Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular Device

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1768228

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1768228

Cardiac Safety Services

PUBLISHED:
PAGES: 274 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Cardiac Safety Services Market to Reach US$1.6 Billion by 2030

The global market for Cardiac Safety Services estimated at US$885.9 Million in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. ECG / Holter Measurement, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$475.5 Million by the end of the analysis period. Growth in the Blood Pressure Measurement segment is estimated at 10.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$228.4 Million While China is Forecast to Grow at 13.4% CAGR

The Cardiac Safety Services market in the U.S. is estimated at US$228.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$361.8 Million by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global Cardiac Safety Services Market - Key Trends & Drivers Summarized

Why Are Cardiac Safety Services Critical in Clinical Trials?

Cardiac safety services are essential in clinical trials, particularly those involving new pharmaceuticals, as they ensure that the drugs being tested do not have adverse effects on the heart. These services monitor and assess potential cardiac risks such as arrhythmias, QT prolongation, and other cardiovascular side effects that could arise from drug therapies. With regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) placing stringent guidelines on cardiac safety assessments during clinical trials, companies must comply with comprehensive cardiac safety protocols to ensure that new drugs are safe for patients.

Cardiac safety services include a range of diagnostic evaluations such as electrocardiograms (ECGs), Holter monitoring, blood pressure monitoring, and echocardiography. These assessments help detect early signs of cardiotoxicity and guide decisions on the continuation, modification, or cessation of a drug’s development. As drug development processes become increasingly focused on patient safety and long-term cardiovascular health outcomes, cardiac safety services are becoming indispensable in ensuring that therapies are safe not only for short-term use but also for chronic administration in vulnerable populations, including the elderly and those with pre-existing heart conditions.

How Are Technological Advancements Shaping the Cardiac Safety Services Market?

Technological advancements are significantly enhancing the accuracy, efficiency, and capabilities of cardiac safety services in clinical trials. One of the most notable advancements is the use of digital technologies and wearables for continuous cardiac monitoring. Devices like portable ECG monitors and wearable heart monitors allow for real-time tracking of cardiac activity over extended periods, offering a more comprehensive view of a patient’s heart health during drug trials. These technologies not only provide high-resolution data but also allow for remote monitoring, enabling more flexible trial designs and reducing the need for patients to visit clinical sites frequently.

Moreover, advancements in artificial intelligence (AI) and machine learning (ML) are revolutionizing the way cardiac safety data is analyzed. AI-driven platforms can rapidly process large volumes of cardiac data, identifying subtle patterns and abnormalities that may not be immediately apparent to human analysts. These technologies are also improving the predictive capabilities of cardiac assessments, enabling earlier detection of potential risks and enhancing decision-making throughout the drug development process. Additionally, cloud-based solutions are facilitating the secure sharing of cardiac safety data between trial sites and sponsors, improving collaboration and speeding up the regulatory submission process. These innovations are increasing the reliability and accessibility of cardiac safety services, helping pharmaceutical companies streamline their clinical trials.

What Industry Trends Are Driving the Demand for Cardiac Safety Services?

Several industry trends are driving the rising demand for cardiac safety services, particularly the increasing complexity of clinical trials and the regulatory environment’s growing emphasis on cardiovascular safety. As pharmaceutical companies develop more sophisticated therapies targeting conditions like cancer, autoimmune diseases, and metabolic disorders, many of these drugs come with a higher potential for cardiovascular side effects. This is especially true for biologics, immunotherapies, and gene therapies, where cardiac monitoring becomes critical in ensuring patient safety. The high stakes associated with these therapies, combined with stringent regulatory oversight, are pushing companies to invest heavily in comprehensive cardiac safety services to de-risk their clinical programs.

Another important trend is the growing focus on precision medicine and patient-centric trials. As drug developers tailor therapies to specific genetic profiles and subpopulations, the cardiac safety risks associated with personalized treatments can vary significantly. This necessitates more targeted cardiac monitoring and safety assessments. Additionally, the increasing incidence of chronic diseases, particularly cardiovascular diseases, among aging populations is driving demand for more extensive cardiac safety evaluations in clinical trials, as patients with pre-existing conditions often participate in drug studies. The rise of decentralized and hybrid clinical trials, in which patients can participate from home, is also boosting the need for advanced remote cardiac monitoring solutions.

Growth in the Cardiac Safety Services Market Is Driven by Several Factors

Growth in the cardiac safety services market is driven by several factors, including the rising complexity of clinical trials, advancements in monitoring technologies, and increasing regulatory requirements for cardiovascular safety assessments. As the pharmaceutical industry develops more targeted and high-risk therapies, cardiac safety monitoring has become an integral part of the drug development process to ensure patient safety. The rising incidence of cardiovascular diseases and other chronic conditions in clinical trial populations further emphasizes the need for stringent cardiac safety protocols.

Technological advancements, such as AI-powered analytics, wearable ECG devices, and cloud-based platforms, are also propelling market growth by improving the accuracy, accessibility, and efficiency of cardiac safety assessments. These innovations are particularly important in decentralized clinical trials, which rely on remote monitoring technologies to collect real-time cardiac data from patients participating outside of traditional trial sites. Moreover, the increasing focus on personalized medicine is driving demand for customized cardiac safety solutions tailored to specific patient subgroups, requiring specialized monitoring and data analysis.

Another key driver of market growth is the expansion of global clinical trials, particularly in emerging markets. As pharmaceutical companies broaden their clinical research activities to new regions, they require localized cardiac safety services that comply with regional regulatory standards while maintaining high levels of precision and consistency. This trend is further supported by the increasing complexity of regulatory requirements, as health authorities worldwide demand more rigorous cardiovascular safety data during the drug approval process. These factors, combined with the growing adoption of advanced technologies, are expected to drive the sustained growth of the cardiac safety services market.

SCOPE OF STUDY:

The report analyzes the Cardiac Safety Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, Other Service Types); End-Use (Pharma & Biopharma Companies, Contract Research Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Banook Group
  • Bioclinica (A Subsidiary of Cinven)
  • BioTelemetry, Inc.
  • Biotrial
  • Celerion, Inc.
  • Certara, L.P.
  • ERT, Inc.
  • IQVIA
  • Labcorp
  • Medpace
  • Ncardia
  • Pharmaceutical Product Development LLC
  • PhysioStim
  • Richmond Pharmacology
  • SGS S.A.
  • Shanghai Medicilon Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP21437

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Cardiac Safety Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Drug-Induced Cardiotoxicity Drives Demand for Cardiac Safety Assessment Services
    • Increasing Emphasis on Patient Safety and Regulatory Compliance Strengthens Market Demand for Cardiac Safety Monitoring in Clinical Trials
    • Growth in Drug Development and Clinical Research Activities Expands Addressable Market for Cardiac Safety Services
    • Technological Advancements in Cardiac Imaging and Biomarkers Propel Adoption of Advanced Cardiac Safety Assessment Methods
    • Rising Demand for Comprehensive ECG and QT Interval Monitoring in Clinical Trials Boosts Cardiac Safety Service Market
    • Growing Focus on Early Detection of Cardiotoxicity in Oncology and Immunotherapy Creates New Growth Opportunities in Cardiac Safety Services
    • Expansion of Contract Research Organizations (CROs) and Outsourcing of Cardiac Safety to Specialized Providers Fuels Market Growth
    • Increasing Use of Wearable and Remote Monitoring Devices in Clinical Trials Enhances Real-Time Cardiac Safety Data Collection
    • Growing Integration of AI and Machine Learning in Cardiac Safety Analytics Improves Predictive Capabilities and Efficiency
    • Rising Adoption of Electrocardiographic Monitoring in Early-Phase Clinical Trials Strengthens Market for Cardiac Safety Services
    • Increasing Demand for Non-Invasive Cardiac Monitoring Methods Expands Scope of Cardiac Safety Services in Diverse Patient Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Cardiac Safety Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cardiac Safety Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for ECG / Holter Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for ECG / Holter Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for ECG / Holter Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Blood Pressure Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Blood Pressure Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Blood Pressure Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiovascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiovascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cardiovascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Thorough QT Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Thorough QT Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Thorough QT Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • CHINA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiac Safety Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiac Safety Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • INDIA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiac Safety Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiac Safety Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!